Tesamorelin

TSM10 is a catalog designation commonly used in research-peptide supply chains to refer to a 10 mg vial of Tesamorelin. Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH) designed for controlled laboratory studies involving metabolic pathways, endocrine signaling, adipose-tissue biology, and pituitary receptor research.

Although the commercial product name varies among vendors, TSM10 typically contains Tesamorelin in lyophilized (freeze-dried) form, supplied without excipients unless otherwise specified.

Tesamorelin is a 44-amino-acid peptide that mimics endogenous GHRH with enhanced stability. It interacts with GHRH receptors on pituitary somatotroph cells, making it a valuable tool in research exploring:

• Growth hormone release pathways

• IGF-1 axis modulation

• Visceral adipose tissue biology

• Metabolic and endocrine regulation

Researchers may select TSM10 for in-vitro or ex-vivo studies where a stable GHRH analog is required.